Stoke Therapeutics (STOK)
(Delayed Data from NSDQ)
$12.41 USD
+0.72 (6.16%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $12.40 -0.01 (-0.08%) 7:20 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -0.60 |
EPS Last Quarter | -0.60 |
Last EPS Surprise | 3.23% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.28 |
Next Year | -2.71 |
EPS (TTM) | -2.37 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.33M | 3.33M | 12.57M | 10.96M |
# of Estimates | 4 | 4 | 4 | 3 |
High Estimate | 4.00M | 4.00M | 15.00M | 15.00M |
Low Estimate | 2.32M | 2.32M | 9.29M | 8.58M |
Year ago Sales | 5.15M | -2.48M | 8.78M | 12.57M |
Year over Year Growth Est. | -35.34% | 234.27% | 43.19% | -12.85% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.60 | -0.52 | -2.28 | -2.71 |
# of Estimates | 5 | 4 | 6 | 5 |
Most Recent Consensus | -0.54 | -0.43 | -2.39 | -2.46 |
High Estimate | -0.54 | -0.43 | -2.00 | -2.35 |
Low Estimate | -0.70 | -0.63 | -2.62 | -3.45 |
Year ago EPS | -0.53 | -0.69 | -2.38 | -2.28 |
Year over Year Growth Est. | -13.21% | 24.64% | 4.20% | -19.04% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 2 | 1 |
Up Last 60 Days | 1 | 1 | 3 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 2 | 1 |
Down Last 60 Days | 1 | 1 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.60 | -0.52 | -2.28 | -2.71 |
7 Days Ago | -0.60 | -0.52 | -2.28 | -2.71 |
30 Days Ago | -0.59 | -0.57 | -2.30 | -2.78 |
60 Days Ago | -0.56 | -0.48 | -2.28 | -2.53 |
90 Days Ago | -0.56 | -0.48 | -2.37 | -2.60 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.60 | -0.52 | -2.34 | -2.81 |
Zacks Consensus Estimate | -0.60 | -0.52 | -2.28 | -2.71 |
Earnings ESP | 0.00% | 0.00% | -2.46% | -3.35% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.60 | -0.55 | -0.69 | -0.53 | NA |
Estimate | -0.62 | -0.65 | -0.65 | -0.70 | NA |
Difference | 0.02 | 0.10 | -0.04 | 0.17 | 0.06 |
Surprise | 3.23% | 15.38% | -6.15% | 24.29% | 9.19% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more